Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More
At NHS Lothian, High-Throughput NxTAG® RPP Streamlines Respiratory Testing
Test replaced LDT, offering better ease of use and more comprehensive targets
At the Royal Infirmary of Edinburgh Clinical Virology Department, respiratory testing can be a full-time task. As part of the NHS Lothian Laboratory Medicine, the group covers all aspects of viral testing for Edinburgh and surrounding areas, and also serves as a referral lab for other regions of Scotland. The lab receives a total of 100,000 samples and runs 1 million tests per year, with approximately 30,000 of those samples involving respiratory assays.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
January 2
Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio
November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results
October 18
Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio
October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018
September 11
Luminex Corporation Declares Third Quarter Cash Dividend
xMAP® Connect Amsterdam
6-7 November
Amsterdam, Netherlands
